| Literature DB >> 32256951 |
Tamaeh Monteiro-Alfredo1,2,3, Paulo Matafome2,3,4, Bianca Pancoti Iacia1, Kátia Ávila Antunes1, Jéssica Maurino Dos Santos1, Janielle da Silva Melo da Cunha1, Sara Oliveira2,3, Alex Santos Oliveira1, Jaqueline Ferreira Campos1, Mariana Magalhães3, Célia Cabral3,5, Raquel Seiça2,3, Cláudia Andrea Lima Cardoso6, Caio Fernando Ramalho de Oliveira1, Edson Lucas Dos Santos1, Kely de Picoli Souza1.
Abstract
Oxidative stress is a metabolic disorder linked with several chronic diseases, and this condition can be improved by natural antioxidants. The fruit pulp of the palm Acrocomia aculeata (Jacq.) Lodd. ex Mart. is widely used in the treatment of various illnesses, but as far as we know, there are no reports regarding the properties of its leaves. Thus, we aimed to evaluate the antioxidant activity of A. aculeata leaf extracts obtained with water (EA-Aa), ethanol (EE-Aa), and methanol (EM-Aa) solvents. The extracts were chemically characterized, and their antioxidant activity was assessed through the scavenging of the free radicals DPPH and ABTS. EE-Aa and EM-Aa showed the highest amounts of phenolic compounds and free radical scavenging activity. However, EA-Aa was more efficient to protect human erythrocytes against AAPH-induced hemolysis and lipid peroxidation. Thus, we further show the antioxidant effect of EA-Aa in preventing AAPH-induced protein oxidation, H2O2-induced DNA fragmentation, and ROS generation in Cos-7 cells. Increased levels of Sirt1, catalase, and activation of ERK and Nrf2 were observed in Cos-7 treated with EA-Aa. We also verify increased survival in nematodes C. elegans, when induced to the oxidative condition by Juglone. Therefore, our results showed a typical chemical composition of plants for all extracts, but the diversity of compounds presented in EA-Aa is involved in the lower toxicity and antioxidant properties provided to the macromolecules tested, proteins, DNA, and lipids. This protective effect also proven in Cos-7 and in C. elegans was probably due to the activation of the Sirt1/Nrf2 pathway. Altogether, the low toxicity and the antioxidant properties of EA-Aa showed in all the experimental models support its further use in the treatment of oxidative stress-related diseases.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32256951 PMCID: PMC7085880 DOI: 10.1155/2020/5238650
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Chromatography analysis of A. aculeata leaves by LC-6AD and GC-MS. (a) EA-Aa, (b) EE-Aa, (c) EM-Aa by LC-6AD, (d) EE-Aa, and (e) EM-Aa analysis by GC-MS.
Chemical composition identified from the LC-PDA of the extracts of A. aculeata leaves (mg · g−1 ± DP).
| Retention time (min) | Peak | Compound | EA-Aa | EE-Aa | EM-Aa |
|---|---|---|---|---|---|
| 2.31 | 1 | Gallic acid | 201.6 ± 1.4 | 159.4 ± 0.9 | 192.9 ± 1.1 |
| 4.91 | 2 | Vanillic acid | 182.4 ± 0.9 | — | — |
| 6.31 | 3 | Caffeic acid | 124.6 ± 1.2 | 119.7 ± 0.7 | 123.4 ± 1.0 |
| 8.83 | 4 | Ferulic acid | 197.9 ± 1.0 | 182.7 ± 1.0 | 189.6 ± 1.3 |
| 21.75 | 5 | Rutin | 74.8 ± 0.4 | 77.3 ± 0.2 | 75.9 ± 0.5 |
| 24.42 | 6 | Quercetin | 88.7 ± 0.2 | 87.6 ± 0.5 | 89.2 ± 0.3 |
Chemical composition identified from the GC-MS of the extracts of A. aculeata leaves (mg · g−1 ± DP).
| Retention time (min) | Peak | Compound | Molar mass | EE-Aa | EM-Aa |
|---|---|---|---|---|---|
| 16.46 | 1 | Campesterol | 400 | 21.0 ± 0.11 | 18.9±−0.33 |
| 17.02 | 2 | Stigmasterol | 412 | 25.7 ± 0.22 | 34.7 ± 0.29 |
| 17.72 | 3 |
| 414 | 60.1 ± 0.25 | 23.2 ± 0.27 |
| 18.89 | 4 | Lupeol | 426 | 49.4 ± 0.57 | 71.6 ± 0.64 |
| 21.01 | 5 | Lupeol acetate | 468 | 52.7 ± 0.63 | 55.1 ± 0.53 |
Antioxidant activity of free radical scavenging DPPH and ABTS of EA-Aa, EE-Aa and EM-Aa (IC50μg·mL−1).
| DPPH | ABTS | |||||
|---|---|---|---|---|---|---|
| IC50 | Maximum activity | IC50 | Maximum activity | |||
|
| % |
| % | |||
| AA | 2.68 ± 0.3 | 10 | 93.8 | 2.1 ± 0.2 | 10 | 98.8 |
| EA-Aa | 117.10 ± 7.3 | 250 | 82.2 | 47.4 ± 10.7 | 500 | 96.4 |
| EE-Aa | 12.92 ± 1.5 | 50 | 88.7 | 13.4 ± 0.4 | 100 | 99.8 |
| EM-Aa | 13.28 ± 1.2 | 100 | 90.8 | 10.5 ± 1.2 | 50 | 100 |
IC50: concentration required to capture 50% of the free radicals from the reaction.
Figure 2Protective effect of A. aculeata extracts in human erythrocytes. (a) Hemolytic effect in human erythrocytes incubated with Aa extracts after 240 min of incubation; no hemolytic effect was observed in EA-Aa, while higher concentrations (500 –1,000 μg·mL−1) of the other Aa extracts and the positive control AA showed hemolysis at the higher concentrations. (b) Antihemolytic effect of erythrocytes incubated with Aa extracts and AAPH (50 mM) after 240 min shows a protective effect of EA-Aa (500–1,000 μg·mL−1) against AAPH-induced hemolysis. (c) MDA produced from AAPH-induced lipid peroxidation shows higher protection against lipid peroxidation in the highest concentrations (500–1,000 μg·mL−1) of EA-Aa. ∗vs. Ctrl in (a); #vs. Ctrl and ∗vs. AAPH in (b) and (c); ∗p < 0.05; ∗∗p < 0.01; ∗∗∗,###p < 0.001.
Figure 3Antioxidant potential of EA-Aa in biomolecules. (a) Protein oxidation induced with AAPH (120 mM) shows a reduction of oxidation with EA-Aa (750–1,000 μg·mL−1). (b) Plasmid DNA fragmentation induced with H2O2 (30%) showing protection by EA (50 μg·mL−1–1,000 μg·mL−1) and positive controls, quercetin, rutin, gallic acid, and catechin. #vs. Ctrl; ∗vs. AAPH/H2O2; ∗∗p < 0.01; ###,∗∗∗p < 0.001.
Figure 4Inhibition of ROS generation by EA-Aa in Cos-7 cells. (a) Viability of Cos-7 cells treated with EA-Aa (500-1,000 μg·mL−1) incubated with or without H2O2 (0.5 μM), shows low cytotoxicity of EA-Aa and protection (750–1,000 μg·mL−1) against H2O2-induced oxidative damage from the decrease of H2O2-induced ROS (stained with DCF) (b) and O2·- generation (stained with DHE) (c) with EA-Aa (500–1,000 μg·mL−1). Representative images of DCF and DHE are shown in (d) and (e), respectively. #vs. control; ∗vs. H2O2; #p < 0.05; ##p < 0.01; ###,∗∗∗p < 0.001.
Figure 5In vivo antioxidant potential of EA-Aa in C. elegans. (a) EA-Aa shows toxicity in the nematodes only in concentrations higher than 1,500 μg·mL−1. (b) Antioxidant potential of EA-Aa (500-1,000 μg·mL−1) prevented Juglone-induced lower C. elegans survival after 4 h. ∗vs. Ctrl; #vs. Juglone;∗,#p < 0.05; ∗∗∗p < 0.01.
Figure 6Mechanisms involved in EA-Aa-mediated protection of Cos-7 cells. Western blot analysis shows that EA-Aa increased the levels of Sirt-1 (a), ERK-Thr202/Tyr204 (c), Nrf2-Ser40 (e), and catalase (f), mostly at 750 μg·mL−1. No alterations were observed in the total levels of ERK (b) and Nrf2 (d). ∗vs. Ctrl, ∗p < 0.05; ∗∗p < 0.01.